Anne M. Phillips - Net Worth and Insider Trading

Anne M. Phillips Net Worth

The estimated net worth of Anne M. Phillips is at least $4,050 dollars as of 2024-11-10. Anne M. Phillips is the Director of Barinthus Biotherapeutics PLC and owns about 3,000 shares of Barinthus Biotherapeutics PLC (BRNS) stock worth over $4,050. Details can be seen in Anne M. Phillips's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anne M. Phillips has not made any transactions after 2021-05-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Anne M. Phillips

To

Anne M. Phillips Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anne M. Phillips owns 3 companies in total, including AMAG Pharmaceuticals Inc (AMAG) , Trevena Inc (TRVN) , and Barinthus Biotherapeutics PLC (BRNS) .

Click here to see the complete history of Anne M. Phillips’s form 4 insider trades.

Insider Ownership Summary of Anne M. Phillips

Ticker Comapny Transaction Date Type of Owner
AMAG AMAG Pharmaceuticals Inc 2020-06-02 director
TRVN Trevena Inc 2022-06-09 director
BRNS Barinthus Biotherapeutics PLC 2021-05-04 director

Anne M. Phillips Latest Holdings Summary

Anne M. Phillips currently owns a total of 1 stock. Anne M. Phillips owns 3,000 shares of Barinthus Biotherapeutics PLC (BRNS) as of May 4, 2021, with a value of $4,050.

Latest Holdings of Anne M. Phillips

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BRNS Barinthus Biotherapeutics PLC 2021-05-04 3,000 1.35 4,050

Holding Weightings of Anne M. Phillips


Anne M. Phillips Form 4 Trading Tracker

According to the SEC Form 4 filings, Anne M. Phillips has made a total of 1 transactions in Barinthus Biotherapeutics PLC (BRNS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Barinthus Biotherapeutics PLC is the acquisition of 3,000 shares on May 4, 2021, which cost Anne M. Phillips around $51,000.

Insider Trading History of Anne M. Phillips

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Anne M. Phillips Trading Performance

GuruFocus tracks the stock performance after each of Anne M. Phillips's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anne M. Phillips is 10.21%. GuruFocus also compares Anne M. Phillips's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anne M. Phillips within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Anne M. Phillips's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Anne M. Phillips

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.4 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.83 LIMIT LIMIT LIMIT LIMIT LIMIT

Anne M. Phillips Ownership Network

Ownership Network List of Anne M. Phillips

No Data

Ownership Network Relation of Anne M. Phillips

Insider Network Chart

Anne M. Phillips Owned Company Details

What does AMAG Pharmaceuticals Inc do?

Who are the key executives at AMAG Pharmaceuticals Inc?

Anne M. Phillips is the director of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .

AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AMAG Pharmaceuticals Inc Insider Transactions

No Available Data

Anne M. Phillips Mailing Address

Above is the net worth, insider trading, and ownership report for Anne M. Phillips. You might contact Anne M. Phillips via mailing address: C/o Trevena, Inc., 1018 West 8th Avenue, King Of Prussia Pa 19406.